Pitt H A, Costrini A M
JAMA. 1979 Mar 2;241(9):908-11.
A prospective, randomized, double-blind study was carried out to determine whether vitamin C prophylaxis, 2.0 g/day, vs placebo prophylaxis would reduce the incidence or morbidity of the common cold and other respiratory illnesses in 674 marine recruits during an eight-week period. Whole-blood ascorbic acid levels measured six weeks after initiation of the study were significantly higher in the vitamin C group. There was no difference between the two groups in the incidence or duration of colds. The vitamin C group rated their colds as being less severe, but this was not reflected in different symptom complexes or in fewer sick-call visits or training days lost. This study and the literature do not support the prophylactic use of vitamin C to prevent the common cold.
开展了一项前瞻性、随机、双盲研究,以确定每日2.0克的维生素C预防措施与安慰剂预防措施相比,是否会降低674名海军新兵在八周内患普通感冒及其他呼吸道疾病的发病率或发病率。研究开始六周后测量的全血维生素C水平在维生素C组中显著更高。两组在感冒的发病率或持续时间上没有差异。维生素C组认为他们的感冒症状较轻,但这在不同的症状组合、较少的病假就诊次数或损失的训练天数中并未体现出来。这项研究和文献不支持预防性使用维生素C来预防普通感冒。